SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.

[Revised] Conclusion of Single Sales Contract or Supply Contract

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SK Biopharmaceuticals (326030 KS)

[Revised] Conclusion of Single Sales Contract or Supply Contract

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Organization of Investor Relations Event

Conclusion of Single Sales Contract or Supply Contract

[Revised] Conclusion of Single Sales Contract or Supply Contract

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)